Susan Griffin

Search results

• 2024

  Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia

  Deng, J., Corbett, M. S., Uphoff, N., Lord, J., Fulbright, H., Griffin, S., Rothery, C. & Hodgson, R., 2 Aug 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2015

  Evidence Review Group's Report: Daclatasvir for treating chronic hepatitis C. Report to NICE.

  Woods, B., Llewellyn, A., Faria, R., Lomas, J., Harden, M., Woolacott, N. F. & Griffin, S., 2015, NICE. 230 p.

  Research output: Book/Report › Commissioned report
• 2013

  Expected health benefits of additional evidence: Principles, methods and applications. A white paper for the Patient-Centered Outcomes Research Institute (PCORI).

  Claxton, K. P., Griffin, S., Koffijberg, H. & McKenna, C., Apr 2013, York, UK: Centre for Health Economics, University of York. 43 p. (CHE Research Paper; no. 83)

  Research output: Book/Report › Commissioned report

  Open Access

  File
• 2005

  A pilot study of value of information analysis to support research recommendations for NICE

  Claxton, K., Eggington, S., Griffin, S., Tappenden, P., Wailoo, A., Ginnelly, L., McCabe, C. & Philips, Z., Jun 2005, York, UK: Centre for Health Economics, University of York. 126 p. (CHE Research Paper)

  Research output: Book/Report › Commissioned report